On the stock market since 1980, it operates in the world of heavy industry. It has 30,000 employees. Now — the numbers.
This is an established company with proven profits.
Revenue is spread across several lines; no single product carries the company.
The gap is $4.5B. In times of high interest rates, a gap like that can squeeze a company.
Executives buying with their own money is usually read as confidence in the company’s future.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Growth: Sales growth trails the sector average.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
The stock trades below its recent peak — about 11% off the top. A pullback, not a collapse.
Over the last 12 months, company executives reported 110 buys and 69 sells. Management buying with its own money is usually read as a good sign.
The average analyst price target is $255 — 20% above today’s price.
It pays out $1.40 per share each year — regular cash for whoever holds the stock.
The company’s market value is 51 times its annual profit. Even a small disappointment could hit the price hard.
The growth engine is running at low revs right now. Report-card grade: 41/100.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 43/100.
On our five-subject report card, RRX sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: RRX is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.